Stay updated on Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Results have been posted and key outcomes are now presented on the page. The updates include the results posting dates and outcome measures such as CBR, ORR, PFS, and OS.
    Difference
    0.4%
    Check dated 2025-11-03T01:21:29.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    1%
    Check dated 2025-10-05T10:30:01.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0.
    Difference
    0.0%
    Check dated 2025-09-28T03:20:36.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. This is a minor update with no other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-13T17:43:31.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T15:27:34.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as various types of antibodies and proteins, while removing several related medical topics and location details.
    Difference
    1%
    Check dated 2025-08-30T12:13:35.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.